Meyka Pro banner
Aclarion, Inc.

Aclarion, Inc. Fundamental Analysis (NASDAQ: ACON)

ACON●NASDAQ
HealthcareMedical - Healthcare Information Services
$1.75
$0.09(5.42%)
U.S. Market opens in 15h 50m

Aclarion, Inc. Fundamental Analysis (NASDAQ: ACON)

Aclarion, Inc. (NASDAQ: ACON) shows moderate financial fundamentals with a PE ratio of -0.30, profit margin of -102.60%, and ROE of -62.91%. The company generates $0.0B in annual revenue with strong year-over-year growth of 65.62%.

Key Strengths

Cash Position290.11%
PEG Ratio-0.00
Current Ratio14.17

Areas of Concern

ROE-62.91%
Operating Margin-107.89%
We analyze ACON's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -7712.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-7712.8/100

We analyze ACON's fundamental strength across five key dimensions:

Efficiency Score

Weak

ACON struggles to generate sufficient returns from assets.

ROA > 10%
-63.86%

Valuation Score

Excellent

ACON trades at attractive valuation levels.

PE < 25
-0.30
PEG Ratio < 2
-0.00

Growth Score

Excellent

ACON delivers strong and consistent growth momentum.

Revenue Growth > 5%
65.62%
EPS Growth > 10%
99.82%

Financial Health Score

Excellent

ACON maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
14.17

Profitability Score

Weak

ACON struggles to sustain strong margins.

ROE > 15%
-6290.91%
Net Margin ≥ 15%
-102.60%
Positive Free Cash Flow
No

Key Financial Metrics

Is ACON Expensive or Cheap?

P/E Ratio

ACON trades at -0.30 times earnings. This suggests potential undervaluation.

-0.30

PEG Ratio

When adjusting for growth, ACON's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Aclarion, Inc. at 0.31 times its book value. This may indicate undervaluation.

0.31

EV/EBITDA

Enterprise value stands at -1.89 times EBITDA. This is generally considered low.

-1.89

How Well Does ACON Make Money?

Net Profit Margin

For every $100 in sales, Aclarion, Inc. keeps $-102.60 as profit after all expenses.

-102.60%

Operating Margin

Core operations generate -107.89 in profit for every $100 in revenue, before interest and taxes.

-107.89%

ROE

Management delivers $-62.91 in profit for every $100 of shareholder equity.

-62.91%

ROA

Aclarion, Inc. generates $-63.86 in profit for every $100 in assets, demonstrating efficient asset deployment.

-63.86%

Following the Money - Real Cash Generation

Operating Cash Flow

Aclarion, Inc. generates limited operating cash flow of $-9.28M, signaling weaker underlying cash strength.

$-9.28M

Free Cash Flow

Aclarion, Inc. generates weak or negative free cash flow of $-9.32M, restricting financial flexibility.

$-9.32M

FCF Per Share

Each share generates $-3.23 in free cash annually.

$-3.23

FCF Yield

ACON converts -1.86% of its market value into free cash.

-1.86%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.30

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.31

vs 25 benchmark

P/S Ratio

Price to sales ratio

48.99

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

14.17

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.63

vs 25 benchmark

ROA

Return on assets percentage

-0.64

vs 25 benchmark

ROCE

Return on capital employed

-0.72

vs 25 benchmark

How ACON Stacks Against Its Sector Peers

MetricACON ValueSector AveragePerformance
P/E Ratio-0.3030.84 Better (Cheaper)
ROE-62.91%573.00% Weak
Net Margin-10260.05%5349.00% Weak
Debt/Equity0.00-0.03 (disorted) Distorted
Current Ratio14.175.76 Strong Liquidity
ROA-63.86%-254.00% (disorted) Weak

ACON outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aclarion, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-99.99%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

99.99%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

99.96%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ